Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes

NCT02912455 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02912455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02912455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Terminated
Start date
January 5, 2017
Completion date
July 19, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, obesity